Norway won’t give Oxford-AstraZeneca vaccine to over 65s
MHRA assures UK vaccine recipients that jab is safe for all adults
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Norway will not offer the AstraZeneca vaccine against Covid-19 to individuals over the age of 65, the Norwegian Institute of Public Health (FHI) said on Thursday, making it the latest European country to restrict its use.
Roughly 135,000 individuals in Norway have received their first coronavirus vaccine, with 35,000 having received their second jab, from vaccines made by Moderna and Pfizer, the agency said
However, the FHI has said it will not be administering AstraZeneca's Covid vaccine to people in older age groups, suggesting the smaller number of participants above the age of 65 in the trial conducted by the British-Swedish drug maker.
This move follows that of health officials in France, Germany, Italy, Sweden and Poland, who have advised against its use for those over the age of 65, citing a lack of data on its efficacy in older people.
However, these concerns have been disputed by some, with Dr June Raine, the UK Medicines and Healthcare products Regulatory Agency (MHRA) chief executive, saying: "Current evidence does not suggest any lack of protection against Covid-19 in people aged 65 or over who receive the Covid-19 vaccine AstraZeneca.
"The data we have show that the vaccine produces a strong immune response in the over-65s, and that it is safe," she added.
Subscribe to Independent Premium to bookmark this article
Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments